Healthcare / Health Information ServicesASX
$0.04
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-1.5M · quality 50.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$24M
P/E
N/A
•EV/EBITDA
N/A
•ROE
3472.0%
↑Gross Margin
100.0%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
-19.3%
FCF CAGR
—
FCF margin
-521.7%
FCF / Net income
0.66x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $397637.0 · net income $-3.1M · FCF $-2.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $397637.00 | $397637.00 | $613607.00 | $880760.00 | $755974.00 |
| Net Income | $-3.1M | $-3.1M | $-1.7M | $-2.1M | $-1.1M |
| EBITDA | $-2.7M | $-2.7M | $-1.7M | $-2.1M | $-1.1M |
| EPS | -0.02 | -0.02 | -0.02 | -0.03 | — |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -811.4% | -811.4% | -380.6% | -280.1% | -215.0% |
| Net Margin | -787.2% | -787.2% | -281.3% | -236.8% | -151.3% |
| Balance Sheet | |||||
| Debt/Equity | — | — | -0.74 | — | — |
| Current Ratio | 2.44 | 2.44 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.1M | $-2.1M | $-1.4M | $-1.5M | $-918125.00 |
| Returns | |||||
| ROE | 3472.0% | 3472.0% | 427.7% | -781.1% | -52.3% |
| Valuation | |||||
| P/B | — | — | — | 10.82 | — |
| Growth & Yield | |||||
| Revenue Growth | -35.2% | -35.2% | -30.3% | 16.5% | — |
| EPS Growth | 11.7% | 11.7% | 43.7% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+69.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.02 → -0.02
Residual
+69.6%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.